Pharmacogenomics of medications given via nonconventional administration routes: a scoping review - Supplementary Information

<strong>Table S1: </strong>Characteristics of included pharmacogenomics studies involving intramuscular administration routes <strong>Table S2: </strong>Outcomes and results of included pharmacogenomics studies on intramuscular administration routes <strong>Table S3: </strong>Characteristics of included pharmacogenomic studies on intrathecal/intraventricular administration routes <strong>Table S4: </strong>Outcomes and results of included pharmacogenomics studies on intrathecal/intraventricular administration routes <strong>Table S5: </strong>Characteristics of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes <strong>Table S6: </strong>Outcomes and results of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes <strong>Table S7: </strong>Characteristics of included pharmacogenomics studies on topical/intralesional and transdermal administration routes <strong>Table S8: </strong>Outcomes and results of included pharmacogenomics studies on topical/intralesional administration routes <strong>Table S9: </strong>Outcomes and results of included pharmacogenomics studies on transdermal administration routes <strong>Table S10</strong>: Recommendations for Medications Given via a Non-Conventional Administration Route Provided by Pharmacogenomic Associations <br>